BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23374238)

  • 1. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
    Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
    Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
    Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
    Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric ependymomas: will molecular biology change patient management?
    Grill J; Bergthold G; Ferreira C
    Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymomas of the adult: molecular biology and treatment.
    Rudà R; Gilbert M; Soffietti R
    Curr Opin Neurol; 2008 Dec; 21(6):754-61. PubMed ID: 18989122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial ependymoma: factors affecting outcome.
    Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F
    Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
    Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
    Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
    Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
    J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Ependymoma.
    Vitanza NA; Partap S
    J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Management of Pediatric Ependymomas.
    Lin FY; Chintagumpala M
    Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
    Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
    Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression alterations define unique molecular characteristics of spinal ependymomas.
    Lourdusamy A; Rahman R; Grundy RG
    Oncotarget; 2015 Aug; 6(23):19780-91. PubMed ID: 25909290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and molecular distinctions in spinal ependymomas: A review.
    Connolly ID; Ali R; Li Y; Gephart MH
    Clin Neurol Neurosurg; 2015 Dec; 139():210-5. PubMed ID: 26519890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared molecular targets in pediatric gliomas and ependymomas.
    Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
    Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
    Dorfer C; Tonn J; Rutka JT
    Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial ependymomas of childhood: current management strategies.
    Smyth MD; Horn BN; Russo C; Berger MS
    Pediatr Neurosurg; 2000 Sep; 33(3):138-50. PubMed ID: 11096361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latest classification of ependymoma in the molecular era and advances in its treatment: a review.
    Yamaguchi J; Ohka F; Motomura K; Saito R
    Jpn J Clin Oncol; 2023 Jul; 53(8):653-663. PubMed ID: 37288489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?
    Kim KT; Lee CH; Chung CK; Kim JH
    World Neurosurg; 2018 Oct; 118():e906-e917. PubMed ID: 30031196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ependymoma: Evaluation and Management Updates.
    Rudà R; Bruno F; Pellerino A; Soffietti R
    Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
    Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
    Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.